| abstract |
FIELD: biotechnology, medicine, veterinary, in particular inhibition of vegetative and spore cell (Bacillus anthracis) vitality and malignant anthrax prophylaxis. n SUBSTANCE: invention relates to agent of bactericide action in relates to vegetative spore cells Bacillus anthracis. Agent contains bacteriolytic complex produced by Lysobacter sp.XL1. In method for malignant anthrax prophylaxis bacteriolytic complex produced by abovementioned bacterium strain is used as active ingredient. Said method includes subdermal injection in one dose not later than 3 hours after contamination, or application of dressing (drape) impregnated with active ingredient on place of possible exciter penetration, or treatment of possible contamination focus with aerosol. n EFFECT: bactericide agent without side effects and decreased prophylaxis time. n 6 cl, 8 ex, 8 tbl |